FEnofibRate as a Metabolic INtervention for COVID-19
Condition: Covid19 Interventions: Other: Fenofibrate; Other: Placebo; Other: Usual care Sponsors: University of Pennsylvania; University of Arizona Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2020 Category: Research Source Type: clinical trials
Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
Condition: Neonatal Jaundice Interventions: Drug: Fenofibrate; Drug: Placebo Sponsor: Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2020 Category: Research Source Type: clinical trials
Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study
DiscussionThe STAFENO trial will address whether combination treatment of statin and fenofibrate has an additive beneficial effect compared to statin alone on the reduction and stabilization of plaque and CV events in non-diabetic, combined dyslipidemia patients with non-intervened intermediate CAD.Trial registrationClinicalTrials.gov,NCT02232360. Registered 9 February 2014.https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0004ULE&selectaction=Edit&uid=U00023SZ&ts=2&cx=juppd2 (Source: Trials)
Source: Trials - April 21, 2020 Category: Research Source Type: clinical trials
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Condition: Dyslipidemias Intervention: Drug: Fenofibrate Sponsor: Daewon Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2019 Category: Research Source Type: clinical trials
A Multi-center, Randomized, Double-blind, Parallel Phase Ⅳ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Condition: Dyslipidemias Intervention: Drug: Fenofibrate Sponsor: Daewon Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2019 Category: Research Source Type: clinical trials
